Frontiers in Immunology (Feb 2024)

SOCS1 expression in cancer cells: potential roles in promoting antitumor immunity

  • Subburaj Ilangumaran,
  • Yirui Gui,
  • Akhil Shukla,
  • Sheela Ramanathan

DOI
https://doi.org/10.3389/fimmu.2024.1362224
Journal volume & issue
Vol. 15

Abstract

Read online

Suppressor of cytokine signaling 1 (SOCS1) is a potent regulator immune cell responses and a proven tumor suppressor. Inhibition of SOCS1 in T cells can boost antitumor immunity, whereas its loss in tumor cells increases tumor aggressivity. Investigations into the tumor suppression mechanisms so far focused on tumor cell-intrinsic functions of SOCS1. However, it is possible that SOCS1 expression in tumor cells also regulate antitumor immune responses in a cell-extrinsic manner via direct and indirect mechanisms. Here, we discuss the evidence supporting the latter, and its implications for antitumor immunity.

Keywords